Rx Medical Food Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-09　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 28,927.5 Mn
2033 年預估規模: USD 46,711.8 Mn
年複合成長率 CAGR: 7.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-02-09頁數 152報告編號 CMI909

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Rx Medical Food Market, By Product Type (Pills, Powder, Liquid, Others (Wafers, Chewable, and Bars)), By Therapeutic Application (Pain Management, Neurological Disorders, Gastrointestinal Disorders, Pulmonary Disorders, Metabolic Disorders, Others (Fibrosis, Dialysis, AIDS, etc.)), By Distribution Channel (Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have ‘generally recognized as safe’ (GRAS) status. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. Food and Drug Administration separately regulates medical food under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies. Market Dynamics Increasing number of organic strategies such as collaboration by the various regulatory authorities is expected to drive the global Rx medical food market over the forecast period. For instance, in October 2021, Food Safety and Standards Authority of India (FSSAI) had signed an agreement with Ministry of Food Processing Industries (MoFPI) to support Farmer Producer Organizations (FPOs), Micro Level Food Entrepreneurs, Self Help Groups (SHGs) and Producers Cooperatives to improve the standards of their food business. This agreement will include food safety training and Registration & License of the Micro Enterprises. FSSAI and MoFPI support micro enterprises for obtaining FSSAI license and registration. Key features of the study • This report provides an in-depth analysis of the global Rx medical food market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global Rx medical food market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., Lanfam and AlfaSigma S.P.A. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rx medical food market Market Segmentation • By Product Type o Pills o Powder o Liquid o Others (Wafers, Chewable, and Bars) • By Therapeutic Application o Pain Management o Neurological Disorders o Gastrointestinal Disorders o Pulmonary Disorders o Metabolic Disorders o Others (Fibrosis, Dialysis, AIDS, etc.) • By Distribution Channel o Retail Pharmacies o Online Pharmacies • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players o Abbott Laboratories o Danone S.A. o Mead Johnson & Company, LLC o Fresenius Kabi AG o Nestle S.A. o Primus Pharmaceuticals, Inc. o Targeted Medical Pharma Inc. o Pivotal Therapeutics Inc. o VAYA Pharma, Inc. o Lanfam o AlfaSigma S.P.A.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Therapeutic Application  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Regulatory Scenario o Pricing Analysis o PEST Analysis 4. Global Rx Medical Food Market, By Product Type, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Pills  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Powder  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Liquid  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Others (Wafers, Chewable, and Bars)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 5. Global Rx Medical Food Market, By Therapeutic Application, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Pain Management  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Neurological Disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Gastrointestinal Disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Pulmonary Disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Metabolic Disorders  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Others (Fibrosis, Dialysis, AIDS, etc.)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 6. Global Rx Medical Food Market, By Distribution Channel, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 7. Global Rx Medical Food Market, By Region, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2026–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Abbott Laboratories  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Danone S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mead Johnson & Company, LLC.  Company Highlight  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Fresenius Kabi AG  Company Highlight  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Nestle S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Primus Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Targeted Medical Pharma Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Pivotal Therapeutics Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o VAYA Pharma, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Lanfam  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AlfaSigma S.P.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

Abbott LaboratoriesDanone S.A.Mead Johnson & Company, LLCFresenius Kabi AGNestle S.A.Primus Pharmaceuticals, Inc.Targeted Medical Pharma Inc.Pivotal Therapeutics Inc.VAYA Pharma, Inc.LanfamAlfaSigma S.P.A.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們